Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Hemangioblastoma-Related Cardiovascular Complications

Pathophysiological Mechanisms

  • Hemangioblastomas are highly vascular tumors that can cause arteriovenous shunting, potentially leading to high-output cardiac failure, especially in multifocal or diffuse lesions 1

Diagnostic Approaches

  • MRI with contrast is the preferred imaging modality for diagnosing hemangioblastomas 2

Special Considerations in VHL Disease

  • VHL patients require comprehensive surveillance including annual blood pressure monitoring starting at age 2 3
  • Annual plasma or urine metanephrine levels should be checked to rule out pheochromocytoma, which can cause different cardiovascular manifestations 3
  • Brainstem hemangioblastomas occur in 10-25% of VHL patients, with the youngest reported case at age 12 4